MedPath

Restricted Versus Liberal Fluid Intake for Prevention of Bronchopulmonary Dysplasia

Not Applicable
Not yet recruiting
Conditions
Bronchopulmonary Dysplasia
Registration Number
NCT06954142
Lead Sponsor
University Children's Hospital Basel
Brief Summary

The aim of this study is to determine whether restricted fluid intake (135 ±5 mL/kg/day) compared to liberal fluid intake (165 ±5 mL/kg/day) from day 8 of life reduces the incidence of bronchopulmonary dysplasia (BPD) at 36 weeks postmenstrual age or prior death in preterm infants born \<30 weeks gestational age.

Detailed Description

Complications of preterm birth remain the leading cause of death in children under five years of age worldwide, accounting for approximately one million deaths annually. Among the survivors, bronchopulmonary dysplasia (BPD) is the most common severe complication. BPD is a chronic lung disease characterized by prolonged need for respiratory support and oxygen therapy, poor postnatal growth, and long-term impairments in lung function and neurodevelopment.

Despite advancements in neonatal care, BPD is the most common chronic lung disease in infancy and associated with increased mortality, repeated hospitalisation throughout childhood, impaired lung function up into adulthood, and long-term neurodevelopmental impairment. The incidence of BPD has remained stable over the past 15 years. This is likely due to the improved survival of extremely preterm infants, who are at the highest risk for BPD.

A key feature of evolving BPD is the accumulation of interstitial pulmonary edema, which reduces lung compliance and increases the need for respiratory support, thereby perpetuating a cycle of lung damage.

Currently, diuretics are sometimes used to manage pulmonary edema in preterm infants. While they can improve lung function in the short term, they come with potential risks including bone demineralization, nephrotoxicity, electrolyte imbalances, and impaired growth.

As a potentially safer alternative, fluid restriction is sometimes used to prevent or manage pulmonary edema. It is hypothesized to improve lung mechanics and reduce the need for respiratory support, without the adverse effects associated with medications. However, there is no robust evidence on optimal fluid targets in these patients.

SwissNeoNet, consisting of all nine Swiss NICUs, is a mandatory national registry, where data on all infants born before 32 weeks of gestation and/or with a birth weight \< 1501 g are collected. Fluid management practices vary among Swiss neonatal intensive care units (NICUs) following international guidelines recommending 135 to 180 mL/kg/day of fluids. This variation may contribute to the differing rates of BPD and mortality observed across centers, but fluid intake is not routinely captured in SwissNeoNet data, making it difficult to assess its impact.

In summary, although fluid restriction shows potential as a simple and low-risk intervention to reduce the incidence of BPD, current evidence is insufficient to support its routine use. There is a clear need for a robust, contemporary, and pragmatic trial to evaluate whether fluid restriction, started after the first week of life, can safely and effectively reduce the incidence of BPD or death in very preterm infants.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
750
Inclusion Criteria
  • Hospitalised preterm infants born before 30 weeks 0 days gestation
  • Signed informed consent for further research use of health-related data
Exclusion Criteria
  • congenital malformations
  • diseases likely to affect life expectancy, lung function, fluid strategy, or neurodevelopment
  • renal disease requiring fluid management outside the clinical standard of care
  • congenital heart disease not including patent ductus arteriosus (PDA)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Bronchopulmonary dysplasia (BPD)From enrolment to 36 weeks postmenstrual age

Proportion of infants with BPD measured at 36 weeks postmenstrual age or prior death.

Secondary Outcome Measures
NameTimeMethod
Complications of prematurityFrom enrolment to 36 weeks postmenstrual age

Major complications of prematurity including necrotising enterocolitis ≥ Bell's stage 2, retinopathy of prematurity requiring treatment, patent ductus arteriosus requiring treatment, abnormal brain ultrasound, late onset sepsis

Need of respiratory supportAt first discharge home, on average 37 weeks postmenstrual age

Duration of mechanical ventilation, non-invasive respiratory support, total positive pressure support, supplemental oxygen support, supplemental home oxygen, home ventilation

Days to reach full feedsFrom enrolment to 36 weeks postmenstrual age

Days to reach full feeds defined as 150 ml/kg/d or being off parenteral nutrition

Need of diureticsFrom enrolment to 36 weeks postmenstrual age

Treatment with diuretics (days on diuretics)

Need of corticosteroidsFrom enrolment to 36 weeks postmenstrual age

Systemic postnatal corticosteroids for prevention or treatment of bronchopulmonary dysplasia

Growthat birth and 36 weeks postmenstrual age

difference in weight, length, and head circumference z-score at 36 weeks postmenstrual age and at birth, respectively

Daily caloric intakeFrom enrolment to 36 weeks postmenstrual age

Daily caloric intake from day 8 of life to 36 weeks postmenstrual age

DehydrationFrom enrolment to 36 weeks postmenstrual age

Dehydration (sodium level ≥ 150 mmol/L plus clinical signs of dehydration)

Fluid overloadFrom enrolment to 36 weeks postmenstrual age

Fluid overload (sodium level ≤ 130 mmol/L plus clinical signs of fluid overload)

Age at dischargeAt first discharge home, on average 37 weeks postmenstrual age

Postmenstrual age at discharge home

Tube feedingAt first discharge home, on average 37 weeks postmenstrual age

Tube feeding at discharge home

Trial Locations

Locations (8)

Kantonsspital Aarau AG, Klinik für Kinder u. Jugendliche

🇨🇭

Aarau, Switzerland

Inselspital Bern, Kinderklinik

🇨🇭

Bern, Switzerland

Kantonsspital Graubünden, Departement Kinder- und Jugendmedizin

🇨🇭

Chur, Switzerland

Hôpitaux universitaires de Genève (HUG), Unité de Néonatologie

🇨🇭

Genève, Switzerland

Luzerner Kantonsspital, Kinderspital

🇨🇭

Luzern, Switzerland

Ostschweizer Kinderspital & Neonatologie und Frauenklinik KSSG, Perinatalzentrum St. Gallen

🇨🇭

St. Gallen, Switzerland

UniversitätsSpital Zürich, Klinik für Neonatologie

🇨🇭

Zürich, Switzerland

University Children's Hospital Basel UKBB

🇨🇭

Basel, Switzerland

© Copyright 2025. All Rights Reserved by MedPath